Feature Type | Standardized |
Nominal ANOVA |
||||
---|---|---|---|---|---|---|
mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.0048 | 0.9 |
mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.0035 | 0.9 |
mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |